| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2010 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 29 | Q3 2020 | 90.6% |
| ISHARES TR | 26 | Q4 2020 | 51.7% |
| ISHARES INC | 11 | Q1 2020 | 64.0% |
| ISHARES TR | 11 | Q4 2021 | 47.6% |
| SELECT SECTOR SPDR TR ENERGY | 9 | Q2 2024 | 67.4% |
| ISHARES TR | 9 | Q2 2015 | 34.5% |
| PHATHOM PHARMACEUTICALS INC | 9 | Q2 2022 | 1.1% |
| ISHARES TR RUS 2000 VAL ETF | 7 | Q4 2022 | 47.0% |
| ISHARES TR | 5 | Q2 2024 | 27.2% |
| VANGUARD INTL EQUITY INDEX F | 5 | Q3 2022 | 45.3% |
View Summit Rock Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-01 |
| 13F-HR | 2024-07-25 |
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-01-26 |
| 13F-HR | 2023-10-24 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-01-12 |
| 13F-HR | 2022-11-02 |
| 13F-HR | 2022-08-01 |
View Summit Rock Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.